NCT01933672 Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01933256 Study of Subcutaneous Doses of HIP2B in Subjects With Type 2 Diabetes Mellitus Treated With Metformin Status COMPLETED Phase PHASE1
NCT01919684 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT01918865 Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01915849 Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1/PHASE2
NCT01910441 Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients Status TERMINATED Phase PHASE4
NCT01908348 Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus Status COMPLETED Phase NA
NCT01906359 Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers Status COMPLETED Phase NA
NCT01906294 IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus Status TERMINATED Phase N/A
NCT01894568 A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment Status COMPLETED Phase PHASE3
NCT01890629 Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study) Status COMPLETED Phase PHASE4
NCT01889784 Acute Effect of Phototherapy With Light Emitting Diode (LED) on Muscle and Pulmonary Oxygen Consumption on Diabetes Mellitus Status UNKNOWN Phase NA
NCT01885260 Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01882036 Bariatric Surgery And Adipose Inflammation Dysfunction and Type 2 Diabetes Mellitus Status COMPLETED Phase NA
NCT01881724 Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients Status UNKNOWN Phase NA
NCT01876849 An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01872299 Studies Investigating Co-morbidities Aggravating Heart Failure Status COMPLETED Phase N/A